141 related articles for article (PubMed ID: 34537809)
1. A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma.
Hua X; Ge S; Zhang J; Xiao H; Tai S; Yang C; Zhang L; Liang C
Cell Death Discov; 2021 Sep; 7(1):252. PubMed ID: 34537809
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer.
Ge S; Hua X; Chen J; Xiao H; Zhang L; Zhou J; Liang C; Tai S
Front Genet; 2021; 12():666300. PubMed ID: 34484286
[TBL] [Abstract][Full Text] [Related]
3. A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
Chen B; Yao Y; Mao D; Li C; Wang X; Sheng S; Zhang L; Wang X; Chen S; Xu W; Deng J; Sun C; Zhou Q; Lowe S; Bentley R; Shao W; Li H
Front Immunol; 2022; 13():928742. PubMed ID: 35935979
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features.
Sheng L; Li T; Li Y; Zhou M; Wang J; Lai Y; Zhang Y; Yi P; Mu Q; Ouyang G
Heliyon; 2023 Sep; 9(9):e19342. PubMed ID: 37809743
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
Lin G; Yang Y; Feng Q; Zhan F; Sun C; Niu Y; Li G
Immunogenetics; 2022 Jun; 74(3):285-301. PubMed ID: 35119508
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma.
Tang G; Guan H; Du Z; Yuan W
Front Cell Dev Biol; 2022; 10():816024. PubMed ID: 35663389
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
8. Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Yu W; Lu J; Wu C
Front Genet; 2022; 13():1024096. PubMed ID: 36313434
[TBL] [Abstract][Full Text] [Related]
9. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
11. Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia.
Mao Y; Hu Z; Xu X; Xu J; Wu C; Jiang F; Zhou G
Front Genet; 2022; 13():973319. PubMed ID: 36061194
[TBL] [Abstract][Full Text] [Related]
12. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
14. Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma.
Zhang F; Lin J; Zhu D; Tang Y; Lu Y; Liu Z; Wang X
Front Oncol; 2022; 12():970208. PubMed ID: 36158645
[TBL] [Abstract][Full Text] [Related]
15. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
[TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
17. Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma.
Zhang J; Yan A; Cao W; Shi H; Cao K; Liu X
Cancer Cell Int; 2020 Dec; 20(1):584. PubMed ID: 33372609
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of 7-methylguanosine and immune microenvironment characteristics in clear cell renal cell carcinomas.
Xiao Y; Yang J; Yang M; Len J; Yu Y
Front Genet; 2022; 13():866819. PubMed ID: 36003341
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
[TBL] [Abstract][Full Text] [Related]
20. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y
Front Oncol; 2021; 11():700084. PubMed ID: 34249761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
